Drug Development – Page 9 – Discover Pharma

Welcome to Discover Pharma! Today is : April 20, 2026

Drug Development

Artificial Intelligence,Technology and platforms
QuantHealth introduces clinical-stage AI foundation model for trial design
The new platform, trained on 100 million patient records, aims [...]

May 10, 2025
Clinical Trials,Drug Development,Market Access & Commercialization,Regulatory Affairs
New study urges EU to overhaul regulatory landscape to remain competitive in pharma innovation
Research from Bayes Business School and Merck KGaA identifies barriers [...]

May 6, 2025
Drug Development
SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges
SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

May 6, 2025
Partnerships & Funding,Patient Centricity
Crown Bioscience extends partnership with NEXT Oncology to advance cancer research
May 5, 2025
CDMOs & Manufacturing,Drug Development,Partnerships & Funding
BridgeBio sees strong launch for ATTR-CM drug Attruby and accelerates rare disease pipeline
BridgeBio Pharma reported $36.7 million in US net revenue for [...]

May 1, 2025
Cell & Gene Therapy
BioSkryb Genomics and Tecan launch single-cell multiomics workflow for faster sequencing
April 28, 2025
Clinical Trials
Late-breaking elafibranor data shows potential in primary sclerosing cholangitis (PSC)
April 28, 2025
Drug Development
Glen Clova Scientific relocates R&D operations to support pipeline expansion
Glen Clova Scientific has moved its R&D operations to the [...]

April 28, 2025
Artificial Intelligence
Indegene outlines critical GenAI lessons and strategies for the future of life sciences
April 28, 2025
Artificial Intelligence,Clinical Trials
Lokavant launches AI-powered forecasting tool to cut clinical trial planning time from weeks to minutes
April 25, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK